Sign up to save your podcasts
Or
Share What You Need to Know About Strategies for Treating NPDR
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What You Need to Know About Strategies for Treating NPDR
CME credits: 0.25
Valid until: 28-02-2023
Claim your CME credit at https://reachmd.com/programs/cme/what-you-need-know-about-strategies-treating-npdr/13177/
The results from the Protocol W and PANORAMA clinical trials have sparked a lot of talk in the retina community about what the data really mean. So how should physicians interpret these data, and what is changing for their patients with diabetic retinopathy?
Find out in this activity as Dr. Rahul Khurana and Dr. Jennifer Sun review the findings from both trials and discuss if treatment with anti-VEGF really improves outcomes for patients with moderate to severe NPDR.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 28-02-2023
Claim your CME credit at https://reachmd.com/programs/cme/what-you-need-know-about-strategies-treating-npdr/13177/
The results from the Protocol W and PANORAMA clinical trials have sparked a lot of talk in the retina community about what the data really mean. So how should physicians interpret these data, and what is changing for their patients with diabetic retinopathy?
Find out in this activity as Dr. Rahul Khurana and Dr. Jennifer Sun review the findings from both trials and discuss if treatment with anti-VEGF really improves outcomes for patients with moderate to severe NPDR.
=